4-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline maleate
98%
- Product Code: 46326
CAS:
1350965-83-1
Molecular Weight: | 450.4111 g./mol | Molecular Formula: | C₂₁H₂₁F₃N₄O₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research due to its potential biological activity. It is often investigated for its role as a kinase inhibitor, which makes it a candidate for the development of therapeutics targeting various diseases, particularly cancers. Its ability to modulate specific signaling pathways in cells allows researchers to explore its efficacy in inhibiting tumor growth and proliferation. Additionally, it may be studied for its potential applications in treating neurological disorders, given its structural properties that could influence brain-related targets. The compound is also used in preclinical studies to understand its pharmacokinetics, toxicity, and overall safety profile, which are critical steps in drug development.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.025 | 10-20 days | £215.36 |
+
-
|
4-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline maleate
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research due to its potential biological activity. It is often investigated for its role as a kinase inhibitor, which makes it a candidate for the development of therapeutics targeting various diseases, particularly cancers. Its ability to modulate specific signaling pathways in cells allows researchers to explore its efficacy in inhibiting tumor growth and proliferation. Additionally, it may be studied for its potential applications in treating neurological disorders, given its structural properties that could influence brain-related targets. The compound is also used in preclinical studies to understand its pharmacokinetics, toxicity, and overall safety profile, which are critical steps in drug development.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :